Cleanoz
NDC Package 44929-002-07
Package Information
Cleanoz is recommended for nasal rinsing in babies, children and adults.Recommended for the following cases:Hygiene of nasal passage: Pollution, dry air, airconditioning, dust, pollen.Moisture efficiency.Nasal drainage. Marketed by Laboratoires Gifrer Barbezat, this product is identified by NDC 44929-002 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 1044606 - cleanoz 0.9 % Nasal Solution
- RxCUI: 1044606 - sodium chloride 9 MG/ML Nasal Solution [Cleanoz Saline]
- RxCUI: 1044606 - Cleanoz Saline 0.154 MEQ/ML Nasal Solution
- RxCUI: 1044606 - Cleanoz Saline 0.9 % Nasal Solution
- RxCUI: 1044606 - NaCl 9 MG/ML Nasal Solution [Cleanoz Saline]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 44929 - Laboratoires Gifrer Barbezat
- 44929-002 - Cleanoz
- 44929-002-07 - 30 AMPULE in 1 CARTON / 5 mL in 1 AMPULE (44929-002-01)
- 44929-002 - Cleanoz
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (44929-002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44929-002-07 identifies a specific commercial package of 30 ampule in 1 carton / 5 ml in 1 ampule (44929-002-01) of Cleanoz, labeled by Laboratoires Gifrer Barbezat. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Laboratoires Gifrer Barbezat on November 25, 2008. The current certification is valid through December 31, 2017.
How is this Laboratoires Gifrer Barbezat product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44929000207. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.